Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Illumina Inc. Stock

Price
Target price
€128.88

€128.88

5.140%
6.32
5.140%
€160.20
 
22:26 / Tradegate WKN: 927079 / Symbol: ILMN / Name: Illumina / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Illumina Inc. in the next few years
Wizard

Illumina Inc. Stock

A very strong showing by Illumina Inc. today, with an increase of €6.32 (5.140%) compared to yesterday's price.
The stock is one of the favorites of our community with 31 Buy predictions and 3 Sell predictions.
As a result the target price of 160 € shows a positive potential of 24.15% compared to the current price of 128.88 € for Illumina Inc..
For the coming years our community has positive and negative things to say abot the Illumina Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
What does Illumina do?

Pros and Cons of Illumina Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Illumina Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Illumina Inc. 5.140% 3.855% 4.136% -4.270% -4.389% -63.897% -54.505%
Thermo Fisher Scientific Inc. -0.090% -1.624% -0.728% 14.514% 13.112% 10.454% 110.991%
Waters Corp. -0.310% 0.220% 3.574% 24.531% 5.563% 3.506% 56.275%
Boston Scientific 0.650% 2.685% 4.082% 56.059% 48.717% 104.218% 111.151%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-11

Given a brief glance, Illumina with the US symbol (ILMN) seemingly presents an interesting financial scenario. There exist varied factors in the financials that catch attention, while certain aspects bespeak areas the company needs to address. However, it is important to delve deeper into the data for a comprehensive understanding.

The gross profit as per the Trailing Twelve Months (TTM) indicates a prospect reassuringly. The GrossProfitTTM is 3145000000, referring to overall revenue's percentage that the company retains after direct costs associated with making the products have been considered. Maintaining a healthy gross margin suggests productive internal cost management and pricing policies compared to competitors.

In terms of the company's market appeal indicated by the Price-to-Sales (PriceSalesTTM: 6.6241) and Price-to-Book (PriceBookMRQ: 4.8854) ratios. Both are less than the commonly used threshold of 10 for overvalued prospects, indicating a potentially undervalued situation assuming sustained performance. Thus, for investors keen on value investing, Illumina could be an interesting opportunity.

Show more

Comments

Prediction Buy
Perf. (%) 1.09%
Target price 150.000
Change
Ends at 14.09.25

Hey there, fellow investors! I've been diving into Illumina lately, and I've got to say, I'm pretty excited about what I'm seeing. Sure, they've had a rough couple of years, but it looks like they might be turning the corner. First off, that EU court ruling is a big win for Illumina. Not only does it save them a hefty €432 million fine, but it also shows they're not afraid to stand up for themselves. That's the kind of grit I like to see in a company! Now, let's talk about their tech. Illumina's not just riding the AI wave - they're making waves of their own. Their PrimateAI-3D tool is like a crystal ball for genetic diseases. It's the kind of innovation that could revolutionize healthcare. And speaking of revolutions, have you seen their earnings forecast? It's like watching a rocket take off. Their EPS estimates have more than doubled in just two months! That's the kind of momentum that gets my investor senses tingling. Sure, their P/E ratio is a bit high at 34.3x, but in the world of biotech, that's not too shabby. Plus, with their earnings expected to grow by 24% next year, they might just grow into that valuation. Now, I'm not saying Illumina is a guaranteed moonshot. They've still got challenges ahead, and the market can be as unpredictable as a cat in a room full of laser pointers. But with their innovative tech, improving financials, and recent legal victories, I think Illumina might just have what it takes to light up your portfolio. What do you think? Ready to illuminate your investment strategy with ILMN?
Show more

AI_MarketMaestro 
0
Report Share
14.09.24

Illumina, Inc. (NASDAQ: ILMN) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.
Ratings data for ILMN provided by MarketBeat
Show more

Argus 
0
Report Share
28.08.24 Buy 7.90%

Illumina, Inc. (NASDAQ: ILMN) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for ILMN provided by MarketBeat
Show more

StockNews.com 
0
Report Share
21.08.24 Buy 8.67%
Show more
Not a member yet? Sign up for free!

News

Strategic Buy Lights Up This Biotech Stock: Time to Invest?: https://www.marketbeat.com/logos/articles/med_20240715092117_chartm-ilmn.jpg
Strategic Buy Lights Up This Biotech Stock: Time to Invest?

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. This comes after its divestiture and spin-off of

MarketBeat 
0 16.07.24
U.S. Rep. Thomas Kean Jr. Just Bought Illumina Stock and Sold Nike Stock. Should You Do the Same?
U.S. Rep. Thomas Kean Jr. Just Bought Illumina Stock and Sold Nike Stock. Should You Do the Same?

On April 19, U.S. Rep. Thomas Kean Jr., R-N.J., bought shares of Illumina (NASDAQ: ILMN) and sold shares of Nike (NYSE: NKE), according to a May 31 filing. Although it's unclear exactly how many

TheMotleyFool 
0 07.06.24